CLDN2 and inflammatory bowel disease: In inflammatory bowel diseases, including active ulcerative colitis, there is an up-regulation of claudin-2 protein [6], [11], [10], accompanied by structural changes in the tight junctions; together these may be responsible for the loss of selectivity of tight junctions in patients with inflammatory bowel diseases.